Shexiang Baoxin Pill attenuates myocardial ischemia/reperfusion injury by activating autophagy via modulating the ceRNA-Map3k8 pathway
- PMID: 35849969
- DOI: 10.1016/j.phymed.2022.154336
Shexiang Baoxin Pill attenuates myocardial ischemia/reperfusion injury by activating autophagy via modulating the ceRNA-Map3k8 pathway
Abstract
Background: The pathogenesis of myocardial ischemia/reperfusion is complex, involving multiple regulatory genes and environmental factors, and requiring the simultaneous regulation of multiple targets. Meanwhile, Traditional Chinese Medicine (TCM) has certain advantages in the comprehensive treatment of multi-site, multi-target conditions and overall regulation of this condition. This study explores the effect of the well-known TCM, the Shexiang Baoxin Pill (SBP) on myocardial ischemia/reperfusion injury in mice.
Materials and methods: In vivo, 20 mg/kg/day SBP was administered by gavage for 28 days. In vitro, cardiomyocytes were pretreated with 25 μg/ml SBP for 24 h. Evans blue/TTC double-staining was employed to determine the infarct size. Markers of myocardial injury were detected in the serum and cell supernatants. The changes of pyroptosis and autophagy proteins were detected by western blot. Immunofluorescence, immunohistochemistry and PCR were performed to further illustrate the results.
Results: SBP significantly reduced the myocardial infarct size, decreased the myocardial injury markers, inhibited cardiomyocyte pyroptosis and oxidative stress, and promoted autophagy in vivo. In vitro, SBP alleviated cardiomyocyte pyroptosis, inhibited oxidative stress, reduced IL-1β and IL-18 secretion, and unblocked autophagy flux. Myocardial injury is mitigated by SBP via the rapid degradation of autophagosomes, and SBP promotes the accumulation of autophagosomes by downregulating mmu_circ_0005874, Map3k8 and upregulating mmu-miR-543-3p.
Conclusion: We found for the first time that SBP can inhibit pyroptosis and oxidative stress, and protect from myocardial I/R injury. In addition, it inhibits pyroptosis and improves H/R injury by promoting autophagosome generation and accelerating autophagic flux. SBP interferes with autophagy through the interaction between mmu_circ_0005874/mmu-miR-543-3p/Map3k8.
Keywords: Autophagy; Myocardial ischemia/reperfusion injury; Noncoding RNA; Pyroptosis; Shexiang Baoxin Pill.
Copyright © 2022 The Authors. Published by Elsevier GmbH.. All rights reserved.
Similar articles
-
Single-nucleus ribonucleic acid-sequencing and spatial transcriptomics reveal the cardioprotection of Shexiang Baoxin Pill (SBP) in mice with myocardial ischemia-reperfusion injury.Front Pharmacol. 2023 May 9;14:1173649. doi: 10.3389/fphar.2023.1173649. eCollection 2023. Front Pharmacol. 2023. PMID: 37229263 Free PMC article.
-
Mitigation of myocardial ischemia/reperfusion-induced chronic heart failure via Shexiang Baoxin Pill-mediated regulation of the S1PR1 signaling pathway.Phytomedicine. 2024 Jun;128:155390. doi: 10.1016/j.phymed.2024.155390. Epub 2024 Jan 24. Phytomedicine. 2024. PMID: 38569296
-
Suxiao Jiuxin Pill alleviates myocardial ischemia/reperfusion-induced autophagy via miR-193a-3p/ALKBH5 pathway.Phytomedicine. 2024 Mar;125:155359. doi: 10.1016/j.phymed.2024.155359. Epub 2024 Jan 24. Phytomedicine. 2024. PMID: 38301300
-
Non-coding RNAs modulate pyroptosis in myocardial ischemia-reperfusion injury: A comprehensive review.Int J Biol Macromol. 2024 Feb;257(Pt 1):128558. doi: 10.1016/j.ijbiomac.2023.128558. Epub 2023 Dec 2. Int J Biol Macromol. 2024. PMID: 38048927 Review.
-
Research Progress on the Role of Pyroptosis in Myocardial Ischemia-Reperfusion Injury.Cells. 2022 Oct 18;11(20):3271. doi: 10.3390/cells11203271. Cells. 2022. PMID: 36291138 Free PMC article. Review.
Cited by
-
Study on the Therapeutic Value of Shexiang Tongxin Dropping Pills in Patients with Stable Angina Pectoris of Coronary Heart Disease Complicated with Cognitive Impairment.Actas Esp Psiquiatr. 2024 Feb;52(1):37-44. Actas Esp Psiquiatr. 2024. PMID: 38454898 Free PMC article.
-
Single-nucleus ribonucleic acid-sequencing and spatial transcriptomics reveal the cardioprotection of Shexiang Baoxin Pill (SBP) in mice with myocardial ischemia-reperfusion injury.Front Pharmacol. 2023 May 9;14:1173649. doi: 10.3389/fphar.2023.1173649. eCollection 2023. Front Pharmacol. 2023. PMID: 37229263 Free PMC article.
-
Isoliquiritigenin attenuates myocardial ischemia reperfusion through autophagy activation mediated by AMPK/mTOR/ULK1 signaling.BMC Cardiovasc Disord. 2024 Aug 9;24(1):415. doi: 10.1186/s12872-024-04054-z. BMC Cardiovasc Disord. 2024. PMID: 39123142 Free PMC article.
-
Chinese medicine targets cellular autophagy against cardiovascular diseases: research progress and future prospects.Front Cardiovasc Med. 2025 May 26;12:1585407. doi: 10.3389/fcvm.2025.1585407. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40491718 Free PMC article. Review.
-
METTL3, m6A modification, and EGR1: interplay affecting myocardial I/R injury outcomes.Cell Biol Toxicol. 2024 Dec 21;41(1):7. doi: 10.1007/s10565-024-09937-7. Cell Biol Toxicol. 2024. PMID: 39707117 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous